Hexo Shareholders Approve Tilray Buyout, Company Loses $117 Million In Fiscal Q3

Hexo Corp (TSX: HEXO) shareholders have formally approved the proposed acquisition by Tilray Brands (TSX: TLRY). The approval was granted yesterday at the firms special meeting of shareholders.

The transaction brings to an end the story of yet another cannabis company in the Canadian landscape as consolidation continues in an effort to achieve profitability. The deal will see shareholders receive 0.4352 shares of Tilray for every common share of Hexo held.

READ: Hexo To Be Acquired By Tilray For US$56.0 Million

The arrangement was approved by 93.7% of all votes cast at the meeting.

Hexo will now seek a final order from the Ontario Superior Court of Justice to proceed with the transaction, with the final closing of the arrangement slated to be completed by June 30.

Third quarter decline

At the same time, Hexo last night reported its fiscal third quarter financial results, posting a decline of net revenues of 11% on a quarter over quarter basis, and a 53% decline on a year over year basis, falling to $21.6 million.

Cost of goods sold meanwhile exceeded revenues at $29.1 million, leading to a gross loss before fair value adjustments of $7.5 million. Things got no better from here, with total operating expenses hitting $111.4 million, lead by impairment of property, plant and equipment of $54.9 million and impairments on intangible assets of $18.8 million, presumably in an effort to clean up the balance sheet before merging with Tilray. Transaction costs added a further $19.7 million to the operating expenses.

Overall, the company posted a loss from operations of $120.7 million, leading to a net loss of $117.2 million after certain tax recoveries. Adjusted EBITDA meanwhile came in at negative $3.9 million.

Hexo last traded at $1.00 on the TSX.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Phosphate Gains Danish State Support With LOI For EUR 170 Million Credit Guarantee

Denarius Metals Offers To Acquire Emerita At Just $0.30 A Share

Related News

Tilray: Haywood Reiterates Hold Rating, $16.50 Price Target

With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month,...

Wednesday, May 19, 2021, 03:38:00 PM

Tilray: Cantor Slashes Price Target To $7.40 Ahead Of Earnings

Tilray (TSX: TLRY) is expected to report its second fiscal quarter 2022 results on January...

Friday, January 7, 2022, 03:58:00 PM

Tilray: Analysts Leave Targets Unchanged After MedMen Investment

On August 17, Tilray (NASDAQ: TLRY) made the announcement that they formed a new limited...

Thursday, August 19, 2021, 01:03:00 PM

Tilray Selected To Supply Medical Cannabis For French Experimental Program

Tilray Inc (NASDAQ: TLRY) has expanded its international operations to now include France. The company...

Tuesday, January 26, 2021, 07:55:19 AM

Hexo: Canaccord Raises Price Target To $1.25 Following Q1 Results

Yesterday, Hexo Corp (TSX: HEXO) (NYSE: HEXO) released its fiscal first quarter 2021 financial results....

Tuesday, December 15, 2020, 11:05:36 AM